Opinion

Video

Differential Diagnosis When Considering Hidradenitis Suppurativa in a Patient

Author(s):

Iltefat Hamzavi, MD

A dermatologist provides clinical insights on differential diagnosis strategies when considering hidradenitis suppurativa in patients and the challenges associated with diagnosis.

Video content above is prompted by the following questions:

  • What is in your differential diagnosis when considering hidradenitis suppurativa (HS) in a patient and how is this disease definitively diagnosed?
  • Average delay in HS diagnosis has been found to be around 10 years. What do you think accounts for this and why is it imperative for patients with HS to be diagnosed sooner?
Related Videos
Raj Chovatiya, MD, PhD, MSCI.
1 expert is featured in this series.
Steven Daniel Daveluy, MD, FAAD
1 expert is featured in this series.
Elizabeth Jones, MD, FAAD
1 expert is featured in this series.
Brittany Craiglow, MD, FAAD
Lawrence Eichenfield, MD, FAAD
Related Content
Chronic hand eczema. | Image Credit: IIIRusya - stock.adobe.com
April 22nd 2025

Chronic Hand Eczema Has Significant Impacts on Patients' Lives, Survey Reveals

Cameron Santoro
Dermatology providers reported strong impacts on the work and home life of patients with moderate to severe chronic hand eczema, a manifestation of atopic dermatitis.
Raj Chovatiya, MD, PhD, MSCI
April 9th 2025

Addressing Unmet Needs, Emerging Treatment for Atopic Dermatitis: Raj Chovatiya, MD, PhD

Cameron Santoro Raj Chovatiya, MD, PhD, MSCI
Raj Chovatiya, MD, PhD, MSCI, highlights promising research in atopic dermatitis focused on identifying patient subgroups for targeted treatments and achieving long-term remission.
Migrant Populations. | Image Credit: wladimir1804 - stock.adobe.com
April 9th 2025

Review Explores Skin Health Risks of US Migrant Populations

Cameron Santoro
US migrant populations experience various dermatologic conditions linked to exposures before, during, and after migration, often exacerbated by barriers to accessing health care.
Research presented. | Image Credit: somneuk - stock.adobe.com
April 8th 2025

Managing Skin Conditions: Highlighting Ruxolitinib Cream, Phototherapy Efficacy and Cost

Cameron Santoro
Research presented at the 2025 Academy of Managed Care Pharmacy annual meeting analyzed real-world treatment outcomes for dermatologic conditions, specifically highlighting the efficacy of ruxolitinib cream for atopic dermatitis and the potential for phototherapy to delay costly biologic initiation.
Crystal Aguh, MD, FAAD
March 28th 2025

Bridging Education Gaps in Treatment for Scarring Alopecia With Innovative Approaches

Cameron Santoro Crystal Aguh, MD, FAAD
Crystal Aguh, MD, FAAD, Johns Hopkins School of Medicine faculty, highlights the critical need for comprehensive education on hair loss across diverse hair types, stressing the importance of understanding inflammatory pathways for developing targeted therapies.
Crystal Aguh, MD, FAAD
March 26th 2025

Dermatologists Advocating for Inclusive Hair Loss Research and Treatment in the African Diaspora

Cameron Santoro Crystal Aguh, MD, FAAD
Crystal Aguh, MD, FAAD, Johns Hopkins School of Medicine faculty, advocates for increased funding and education to address hair loss disparities within the African diaspora, emphasizing the need for culturally sensitive treatment and research.

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo